PLAU and viral infectious disease: As shown in Fig. 5A, we analyzed the activity of N6HB426-20 in preventing virus infection in vivo using urokinase-type plasminogen activator/severe combined immunodeficiency (uPA+/+ SCID+/+) mice transplanted with human hepatocytes (37).